StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Research Report on ADXS […]